Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Discrepancies between guidelines and international practice in treatment of hereditary angioedema.

Dispenza MC, Craig TJ.

Allergy Asthma Proc. 2012 May-Jun;33(3):241-8. doi: 10.2500/aap.2012.33.3566.

PMID:
22584193
2.

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.

Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ.

Allergy Asthma Proc. 2012 May-Jun;33(3):235-40. doi: 10.2500/aap.2012.33.3573. Review.

PMID:
22584192
3.

Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.

Bork K.

Immunotherapy. 2014;6(5):533-51. doi: 10.2217/imt.14.33. Epub 2014 Mar 17. Review.

4.

Diagnosis and treatment of hereditary angioedema.

Canonica GW, Rossi O.

Panminerva Med. 2012 Sep;54(3):241-53. Review.

PMID:
22801442
5.

HAE update: determining optimal patient specific therapy.

Gower RG.

Allergy Asthma Proc. 2013 Jan-Feb;34(1):7-12. doi: 10.2500/aap.2013.34.3624. Review.

PMID:
23406928
6.

An evidence based therapeutic approach to hereditary and acquired angioedema.

Bork K.

Curr Opin Allergy Clin Immunol. 2014 Aug;14(4):354-62. doi: 10.1097/ACI.0000000000000082. Review.

PMID:
24983294
7.

Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema.

Jose J, Zacharias J, Craig T.

Clin Rev Allergy Immunol. 2016 Oct;51(2):193-206. doi: 10.1007/s12016-016-8546-7. Review.

PMID:
27129449
8.

Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).

Sabharwal G, Craig T.

Expert Rev Clin Immunol. 2015 Mar;11(3):319-27. doi: 10.1586/1744666X.2015.1012502. Epub 2015 Feb 10. Review.

PMID:
25669442
9.

Treatment of hereditary angioedema: a review (CME).

Bhardwaj N, Craig TJ.

Transfusion. 2014 Nov;54(11):2989-96; quiz 2988. doi: 10.1111/trf.12674. Epub 2014 Apr 16. Review.

PMID:
24735226
10.

The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.

Zanichelli A, Wu MA, Andreoli A, Mansi M, Cicardi M.

Expert Opin Drug Saf. 2015;14(11):1725-36. doi: 10.1517/14740338.2015.1094053. Epub 2015 Oct 1. Review.

PMID:
26429506
11.

Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.

Bernstein JA, Moellman JJ.

Postgrad Med. 2012 May;124(3):91-100. doi: 10.3810/pgm.2012.05.2552. Review.

PMID:
22691903
12.

Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.

Wu MA, Zanichelli A, Mansi M, Cicardi M.

Expert Opin Pharmacother. 2016;17(1):27-40. doi: 10.1517/14656566.2016.1104300. Epub 2015 Oct 29. Review.

PMID:
26512744
13.

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

Bowen T, Cicardi M, Bork K, Zuraw B, Frank M, Ritchie B, Farkas H, Varga L, Zingale LC, Binkley K, Wagner E, Adomaitis P, Brosz K, Burnham J, Warrington R, Kalicinsky C, Mace S, McCusker C, Schellenberg R, Celeste L, Hebert J, Valentine K, Poon MC, Serushago B, Neurath D, Yang W, Lacuesta G, Issekutz A, Hamed A, Kamra P, Dean J, Kanani A, Stark D, Rivard GE, Leith E, Tsai E, Waserman S, Keith PK, Page D, Marchesin S, Longhurst HJ, Kreuz W, Rusicke E, Martinez-Saguer I, Aygören-Pürsün E, Harmat G, Füst G, Li H, Bouillet L, Caballero T, Moldovan D, Späth PJ, Smith-Foltz S, Nagy I, Nielsen EW, Bucher C, Nordenfelt P, Xiang ZY.

Ann Allergy Asthma Immunol. 2008 Jan;100(1 Suppl 2):S30-40. Review.

PMID:
18220150
14.

[Hereditary angioedema: new mechanisms and therapeutic options].

Reshef A, Leibovich I, Goren A, Kidon M.

Harefuah. 2009 Aug;148(8):529-34, 571. Review. Hebrew.

PMID:
19899257
15.

Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.

Craig TJ, Bernstein JA, Farkas H, Bouillet L, Boccon-Gibod I.

Int Arch Allergy Immunol. 2014;165(2):119-27. doi: 10.1159/000368404. Epub 2014 Nov 15.

16.

Optimizing hereditary angioedema management through tailored treatment approaches.

Nasr IH, Manson AL, Al Wahshi HA, Longhurst HJ.

Expert Rev Clin Immunol. 2016;12(1):19-31. doi: 10.1586/1744666X.2016.1100963. Epub 2015 Oct 23. Review.

PMID:
26496459
17.

Facilitating home-based treatment of hereditary angioedema.

Bernstein JA, Riedl M, Zacek L, Shapiro RS.

Allergy Asthma Proc. 2015 Mar-Apr;36(2):92-9. doi: 10.2500/aap.2015.36.3820. Epub 2014 Dec 30. Review.

PMID:
25551795
19.

Update on treatment of hereditary angioedema.

Xu YY, Buyantseva LV, Agarwal NS, Olivieri K, Zhi YX, Craig TJ.

Clin Exp Allergy. 2013 Apr;43(4):395-405. doi: 10.1111/cea.12080. Review.

PMID:
23517035
20.

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.

Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, Bjökander J, Bork K, Bygum A, Cicardi M, de Carolis C, Frank M, Gooi JH, Longhurst H, Martínez-Saguer I, Nielsen EW, Obtulowitz K, Perricone R, Prior N; C-1-INH Deficiency Working Group.

J Allergy Clin Immunol. 2012 Feb;129(2):308-20. doi: 10.1016/j.jaci.2011.11.025. Epub 2011 Dec 24.

PMID:
22197274

Supplemental Content

Support Center